Bio-Rad Laboratories (NYSE:BIO.B) Shares Cross Above Fifty Day Moving Average - Here's Why

Key Points

• Bio-Rad Laboratories' share price has recently exceeded its 50-day moving average of $250.83, trading at a high of $262.57.
• The company reported earnings per share (EPS) of $2.54 for the last quarter and generated revenue of $585.40 million.
• Bio-Rad Laboratories has a market capitalization of $7.14 billion and a debt-to-equity ratio of 0.18, indicating a relatively low level of debt.

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $250.83 and traded as high as $262.57. Bio-Rad Laboratories shares last traded at $262.57, with a volume of 7 shares trading hands.

Bio-Rad Laboratories Stock Performance

The company has a market cap of $6.72 billion, a PE ratio of -3.24 and a beta of 0.81. The business has a 50 day simple moving average of $251.06 and a two-hundred day simple moving average of $269.59. The company has a current ratio of 5.99, a quick ratio of 4.43 and a debt-to-equity ratio of 0.18.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.54 earnings per share for the quarter. The company had revenue of $585.40 million for the quarter. Bio-Rad Laboratories had a positive return on equity of 4.32% and a negative net margin of 85.16%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.